Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 79.17 USD 1.67% Market Closed
Market Cap: 437m USD

Mesa Laboratories Inc
Gross Profit

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Mesa Laboratories Inc
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Mesa Laboratories Inc
NASDAQ:MLAB
Gross Profit
$152.4m
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
13%
Boston Scientific Corp
NYSE:BSX
Gross Profit
$13.3B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Gross Profit
$15.7B
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Gross Profit
$24.6B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
IDEXX Laboratories Inc
NASDAQ:IDXX
Gross Profit
$2.6B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
12%
Intuitive Surgical Inc
NASDAQ:ISRG
Gross Profit
$6.4B
CAGR 3-Years
15%
CAGR 5-Years
17%
CAGR 10-Years
15%
No Stocks Found

Mesa Laboratories Inc
Glance View

Market Cap
436.3m USD
Industry
Health Care

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

MLAB Intrinsic Value
99.87 USD
Undervaluation 21%
Intrinsic Value
Price

See Also

What is Mesa Laboratories Inc's Gross Profit?
Gross Profit
152.4m USD

Based on the financial report for Sep 30, 2025, Mesa Laboratories Inc's Gross Profit amounts to 152.4m USD.

What is Mesa Laboratories Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
13%

Over the last year, the Gross Profit growth was 7%. The average annual Gross Profit growth rates for Mesa Laboratories Inc have been 5% over the past three years , 15% over the past five years , and 13% over the past ten years .

Back to Top